Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.

Tang AT, Sullivan KR, Hong CC, Goddard LM, Mahadevan A, Ren A, Pardo H, Peiper A, Griffin E, Tanes C, Mattei LM, Yang J, Li L, Mericko-Ishizuka P, Shen L, Hobson N, Girard R, Lightle R, Moore T, Shenkar R, Polster SP, Roedel CJ, Li N, Zhu Q, Whitehead KJ, Zheng X, Akers A, Morrison L, Kim H, Bittinger K, Lengner CJ, Schwaninger M, Velcich A, Augenlicht L, Abdelilah-Seyfried S, Min W, Marchuk DA, Awad IA, Kahn ML.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaaw3521. doi: 10.1126/scitranslmed.aaw3521.

PMID:
31776290
2.

Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice.

Girard RA, Chauhan PS, Tucker TA, Allen T, Kaur J, Jeffers A, Koenig K, Florova G, Komissarov AA, Gaidenko TA, Chamiso MB, Fowler J, Morris DE, Sarva K, Singh KP, Idell S, Idell RD.

Exp Brain Res. 2019 Dec;237(12):3419-3430. doi: 10.1007/s00221-019-05682-0. Epub 2019 Nov 16.

PMID:
31734788
3.

A fluorinated phenylbenzothiazole arrest the Trypanosoma cruzi cell cycle and diminishes the mammalian host-cell infection.

Cuevas-Hernández RI, Girard RMBM, Martínez-Cerón S, Santos da Silva M, Elias MC, Crispim M, Trujillo-Ferrara JG, Silber AM.

Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01742-19. doi: 10.1128/AAC.01742-19. [Epub ahead of print]

PMID:
31712204
4.

Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites.

Hobson N, Polster SP, Cao Y, Flemming K, Shu Y, Huston J, Gerrard CY, Selwyn R, Mabray M, Zafar A, Girard R, Carrión-Penagos J, Chen YF, Parrish T, Zhou XJ, Koenig JI, Shenkar R, Stadnik A, Koskimäki J, Dimov A, Turley D, Carroll T, Awad IA.

J Magn Reson Imaging. 2019 Sep 12. doi: 10.1002/jmri.26927. [Epub ahead of print]

PMID:
31515878
5.

A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease.

McKerracher L, Shenkar R, Abbinanti M, Cao Y, Peiper A, Liao JK, Lightle R, Moore T, Hobson N, Gallione C, Ruschel J, Koskimäki J, Girard R, Rosen K, Marchuk DA, Awad IA.

Transl Stroke Res. 2019 Aug 24. doi: 10.1007/s12975-019-00725-8. [Epub ahead of print]

PMID:
31446620
6.

Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations.

Koskimäki J, Zhang D, Li Y, Saadat L, Moore T, Lightle R, Polster SP, Carrión-Penagos J, Lyne SB, Zeineddine HA, Shi C, Shenkar R, Romanos S, Avner K, Srinath A, Shen L, Detter MR, Snellings D, Cao Y, Lopez-Ramirez MA, Fonseca G, Tang AT, Faber P, Andrade J, Ginsberg M, Kahn ML, Marchuk DA, Girard R, Awad IA.

Acta Neuropathol Commun. 2019 Aug 19;7(1):132. doi: 10.1186/s40478-019-0789-0.

7.

Biomarkers of cavernous angioma with symptomatic hemorrhage.

Lyne SB, Girard R, Koskimäki J, Zeineddine HA, Zhang D, Cao Y, Li Y, Stadnik A, Moore T, Lightle R, Shi C, Shenkar R, Carrión-Penagos J, Polster SP, Romanos S, Akers A, Lopez-Ramirez M, Whitehead KJ, Kahn ML, Ginsberg MH, Marchuk DA, Awad IA.

JCI Insight. 2019 Jun 20;4(12). pii: 128577. doi: 10.1172/jci.insight.128577. eCollection 2019 Jun 20.

8.

A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis.

Chapman EM, Lant B, Ohashi Y, Yu B, Schertzberg M, Go C, Dogra D, Koskimäki J, Girard R, Li Y, Fraser AG, Awad IA, Abdelilah-Seyfried S, Gingras AC, Derry WB.

Nat Commun. 2019 Apr 17;10(1):1791. doi: 10.1038/s41467-019-09829-z.

9.

Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.

Awad IA, Polster SP, Carrión-Penagos J, Thompson RE, Cao Y, Stadnik A, Money PL, Fam MD, Koskimäki J, Girard R, Lane K, McBee N, Ziai W, Hao Y, Dodd R, Carlson AP, Camarata PJ, Caron JL, Harrigan MR, Gregson BA, Mendelow AD, Zuccarello M, Hanley DF; MISTIE III Trial Investigators .

Neurosurgery. 2019 Jun 1;84(6):1157-1168. doi: 10.1093/neuros/nyz077.

PMID:
30891610
10.

HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide.

Girard R, Darsigny M, Jones C, Maloum-Rami F, Gélinas Y, Carpentier AC, Laplante M, Perreault N, Boudreau F.

Sci Rep. 2019 Mar 12;9(1):4200. doi: 10.1038/s41598-019-41061-z.

11.

Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.

Shenkar R, Peiper A, Pardo H, Moore T, Lightle R, Girard R, Hobson N, Polster SP, Koskimäki J, Zhang D, Lyne SB, Cao Y, Chaudagar K, Saadat L, Gallione C, Pytel P, Liao JK, Marchuk D, Awad IA.

Stroke. 2019 Mar;50(3):738-744. doi: 10.1161/STROKEAHA.118.024058.

PMID:
30744543
12.

Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes.

Koskimäki J, Girard R, Li Y, Saadat L, Zeineddine HA, Lightle R, Moore T, Lyne S, Avner K, Shenkar R, Cao Y, Shi C, Polster SP, Zhang D, Carrión-Penagos J, Romanos S, Fonseca G, Lopez-Ramirez MA, Chapman EM, Popiel E, Tang AT, Akers A, Faber P, Andrade J, Ginsberg M, Derry WB, Kahn ML, Marchuk DA, Awad IA.

JCI Insight. 2019 Feb 7;4(3). pii: 126167. doi: 10.1172/jci.insight.126167. [Epub ahead of print]

13.

Risk Factors for Recurrent Hematoma After Surgery for Acute Traumatic Subdural Hematoma.

Heino I, Frantzén J, Rinne J, Girard R, Cao Y, Sajanti A, Katila AJ, Posti JP, Takala RSK, Tenovuo O, Koskimäki J.

World Neurosurg. 2019 Jan 10. pii: S1878-8750(19)30023-3. doi: 10.1016/j.wneu.2018.12.155. [Epub ahead of print]

PMID:
30639489
14.

Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.

Girard R, Obeso I, Thobois S, Park SA, Vidal T, Favre E, Ulla M, Broussolle E, Krack P, Durif F, Dreher JC.

Brain. 2019 Jan 1;142(1):146-162. doi: 10.1093/brain/awy298.

PMID:
30590514
15.

Correction for Girard et al., "Uptake of l-Alanine and Its Distinct Roles in the Bioenergetics of Trypanosoma cruzi".

Girard RMBM, Crispim M, Alencar MB, Silber AM.

mSphere. 2018 Dec 12;3(6). pii: e00657-18. doi: 10.1128/mSphere.00657-18. No abstract available.

16.

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.

Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskimäki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad IA.

Neurosurgery. 2019 Dec 1;85(6):843-853. doi: 10.1093/neuros/nyy539.

PMID:
30476251
17.

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.

Lopez-Ramirez MA, Pham A, Girard R, Wyseure T, Hale P, Yamashita A, Koskimäki J, Polster S, Saadat L, Romero IA, Esmon CT, Lagarrigue F, Awad IA, Mosnier LO, Ginsberg MH.

Blood. 2019 Jan 17;133(3):193-204. doi: 10.1182/blood-2018-06-856062. Epub 2018 Nov 15.

PMID:
30442679
18.

Cloning and characterisation of the Equilibrative Nucleoside Transporter family of Trypanosoma cruzi: ultra-high affinity and selectivity to survive in the intracellular niche.

Campagnaro GD, de Freitas Nascimento J, Girard RBM, Silber AM, de Koning HP.

Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2750-2763. doi: 10.1016/j.bbagen.2018.08.015. Epub 2018 Aug 24.

PMID:
30251664
19.

Uptake of l-Alanine and Its Distinct Roles in the Bioenergetics of Trypanosoma cruzi.

Girard RMBM, Crispim M, Alencar MB, Silber AM.

mSphere. 2018 Jul 18;3(4). pii: e00338-18. doi: 10.1128/mSphereDirect.00338-18. Erratum in: mSphere. 2018 Dec 12;3(6):.

20.

Phenotypic characterization of murine models of cerebral cavernous malformations.

Zeineddine HA, Girard R, Saadat L, Shen L, Lightle R, Moore T, Cao Y, Hobson N, Shenkar R, Avner K, Chaudager K, Koskimäki J, Polster SP, Fam MD, Shi C, Lopez-Ramirez MA, Tang AT, Gallione C, Kahn ML, Ginsberg M, Marchuk DA, Awad IA.

Lab Invest. 2019 Mar;99(3):319-330. doi: 10.1038/s41374-018-0030-y. Epub 2018 Jun 26.

21.

[Proper use of fluoroquinolones in hospitalized elderly patients: Realisation of a clinical audit in geriatric hospitals of Lyon University Hospital].

Papailhau C, Gaujard S, Girard R, Bourguignon L, Mouchoux C.

Rev Med Interne. 2018 Jul;39(7):551-556. doi: 10.1016/j.revmed.2018.03.002. Epub 2018 May 18. French.

PMID:
29784465
22.

Development of a bar code-based exposure assessment method to evaluate occupational exposure to disinfectants and cleaning products: a pilot study.

Quinot C, Amsellem-Dubourget S, Temam S, Sevin E, Barreto C, Tackin A, Félicité J, Lyon-Caen S, Siroux V, Girard R, Descatha A, Le Moual N, Dumas O.

Occup Environ Med. 2018 Sep;75(9):668-674. doi: 10.1136/oemed-2017-104793. Epub 2018 May 14.

23.

Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.

Girard R, Zeineddine HA, Koskimäki J, Fam MD, Cao Y, Shi C, Moore T, Lightle R, Stadnik A, Chaudagar K, Polster S, Shenkar R, Duggan R, Leclerc D, Whitehead KJ, Li DY, Awad IA.

Circ Res. 2018 Jun 8;122(12):1716-1721. doi: 10.1161/CIRCRESAHA.118.312680. Epub 2018 May 2.

24.

Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).

Polster SP, Cao Y, Carroll T, Flemming K, Girard R, Hanley D, Hobson N, Kim H, Koenig J, Koskimäki J, Lane K, Majersik JJ, McBee N, Morrison L, Shenkar R, Stadnik A, Thompson RE, Zabramski J, Zeineddine HA, Awad IA.

Neurosurgery. 2019 Apr 1;84(4):954-964. doi: 10.1093/neuros/nyy108.

PMID:
29660039
25.

Estimation of Extra Length of Stay Attributable to Hospital-Acquired Infections in Adult ICUs Using a Time-Dependent Multistate Model.

Ohannessian R, Gustin MP, Bénet T, Gerbier-Colomban S, Girard R, Argaud L, Rimmelé T, Guerin C, Bohé J, Piriou V, Vanhems P.

Crit Care Med. 2018 Jul;46(7):1093-1098. doi: 10.1097/CCM.0000000000003131.

PMID:
29642107
26.

Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter.

Nagampalli RSK, Quesñay JEN, Adamoski D, Islam Z, Birch J, Sebinelli HG, Girard RMBM, Ascenção CFR, Fala AM, Pauletti BA, Consonni SR, de Oliveira JF, Silva ACT, Franchini KG, Leme AFP, Silber AM, Ciancaglini P, Moraes I, Dias SMG, Ambrosio ALB.

Sci Rep. 2018 Feb 22;8(1):3510. doi: 10.1038/s41598-018-21740-z.

27.

Gene editing rescue of a novel MPL mutant associated with congenital amegakaryocytic thrombocytopenia.

Cleyrat C, Girard R, Choi EH, Jeziorski É, Lavabre-Bertrand T, Hermouet S, Carillo S, Wilson BS.

Blood Adv. 2017 Sep 22;1(21):1815-1826. doi: 10.1182/bloodadvances.2016002915. eCollection 2017 Sep 26.

28.

Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis.

Fam MD, Stadnik A, Zeineddine HA, Girard R, Mayo S, Dlugash R, McBee N, Lane K, Mould WA, Ziai W, Hanley D, Awad IA.

Neurosurgery. 2018 Dec 1;83(6):1260-1268. doi: 10.1093/neuros/nyx587.

29.

Treatment of ADHD in patients with bipolar disorder.

Girard R, Joober R.

J Psychiatry Neurosci. 2017 Nov;42(6):E11-E12. No abstract available.

30.

Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.

Lopez-Ramirez MA, Fonseca G, Zeineddine HA, Girard R, Moore T, Pham A, Cao Y, Shenkar R, de Kreuk BJ, Lagarrigue F, Lawler J, Glass CK, Awad IA, Ginsberg MH.

J Exp Med. 2017 Nov 6;214(11):3331-3346. doi: 10.1084/jem.20171178. Epub 2017 Sep 28.

31.

[Integrate the surgical hand disinfection as a quality indicator in an operating room of urology].

Francois M, Girard R, Mauranne CC, Ruffion A, Terrier JE.

Prog Urol. 2017 Dec;27(16):1015-1019. doi: 10.1016/j.purol.2017.08.009. Epub 2017 Sep 22. French.

PMID:
28947339
32.

Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer.

Jovelet C, Madic J, Remon J, Honoré A, Girard R, Rouleau E, André B, Besse B, Droniou M, Lacroix L.

PLoS One. 2017 Aug 22;12(8):e0183319. doi: 10.1371/journal.pone.0183319. eCollection 2017.

33.

Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.

Girard R, Zeineddine HA, Fam MD, Mayampurath A, Cao Y, Shi C, Shenkar R, Polster SP, Jesselson M, Duggan R, Mikati AG, Christoforidis G, Andrade J, Whitehead KJ, Li DY, Awad IA.

Transl Stroke Res. 2018 Feb;9(1):34-43. doi: 10.1007/s12975-017-0561-3. Epub 2017 Aug 17.

34.

Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.

Zeineddine HA, Girard R, Cao Y, Hobson N, Fam MD, Stadnik A, Tan H, Shen J, Chaudagar K, Shenkar R, Thompson RE, McBee N, Hanley D, Carroll T, Christoforidis GA, Awad IA.

J Magn Reson Imaging. 2018 Apr;47(4):1133-1138. doi: 10.1002/jmri.25831. Epub 2017 Aug 9.

35.

Determinants of Implementation of Isolation Precautions Against Infections by Multidrug-Resistant Microorganisms: A Hospital-Based, Multicenter, Observational Study.

Bénet T, Girard R, Gerbier-Colomban S, Dananché C, Hodille E, Dauwalder O, Vanhems P.

Infect Control Hosp Epidemiol. 2017 Oct;38(10):1188-1195. doi: 10.1017/ice.2017.153. Epub 2017 Jul 31.

PMID:
28758615
36.

Heat map for data visualization in infection control epidemiology: An application describing the relationship between hospital-acquired infections, Simplified Acute Physiological Score II, and length of stay in adult intensive care units.

Ohannessian R, Bénet T, Argaud L, Guérin C, Guichon C, Piriou V, Rimmelé T, Girard R, Gerbier-Colomban S, Vanhems P.

Am J Infect Control. 2017 Jul 1;45(7):746-749. doi: 10.1016/j.ajic.2017.02.012. Epub 2017 May 23.

PMID:
28549877
37.

Risk factors for urinary tract infections in geriatric hospitals.

Girard R, Gaujard S, Pergay V, Pornon P, Martin-Gaujard G, Bourguignon L; UTIC Group.

J Hosp Infect. 2017 Sep;97(1):74-78. doi: 10.1016/j.jhin.2017.05.007. Epub 2017 May 16.

PMID:
28526270
38.

Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.

Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N, Girard R, Zeineddine HA, Lightle R, Moore T, Cao Y, Shenkar R, Chen M, Mericko P, Yang J, Li L, Tanes C, Kobuley D, Võsa U, Whitehead KJ, Li DY, Franke L, Hart B, Schwaninger M, Henao-Mejia J, Morrison L, Kim H, Awad IA, Zheng X, Kahn ML.

Nature. 2017 May 18;545(7654):305-310. doi: 10.1038/nature22075. Epub 2017 May 10.

39.

Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.

Fam MD, Hanley D, Stadnik A, Zeineddine HA, Girard R, Jesselson M, Cao Y, Money L, McBee N, Bistran-Hall AJ, Mould WA, Lane K, Camarata PJ, Zuccarello M, Awad IA.

Neurosurgery. 2017 Nov 1;81(5):860-866. doi: 10.1093/neuros/nyx123.

40.
41.

Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity.

Girard R, Météreau E, Thomas J, Pugeat M, Qu C, Dreher JC.

Sci Rep. 2017 Mar 21;7:44917. doi: 10.1038/srep44917.

42.

The fibrinolytic system: A new target for treatment of depression with psychedelics.

Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S.

Med Hypotheses. 2017 Mar;100:46-53. doi: 10.1016/j.mehy.2017.01.013. Epub 2017 Jan 23.

PMID:
28236848
43.

RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.

Shenkar R, Shi C, Austin C, Moore T, Lightle R, Cao Y, Zhang L, Wu M, Zeineddine HA, Girard R, McDonald DA, Rorrer A, Gallione C, Pytel P, Liao JK, Marchuk DA, Awad IA.

Stroke. 2017 Jan;48(1):187-194. doi: 10.1161/STROKEAHA.116.015013. Epub 2016 Nov 22.

44.

LCA of emerging technologies: addressing high uncertainty on inputs' variability when performing global sensitivity analysis.

Lacirignola M, Blanc P, Girard R, Pérez-López P, Blanc I.

Sci Total Environ. 2017 Feb 1;578:268-280. doi: 10.1016/j.scitotenv.2016.10.066. Epub 2016 Nov 8.

45.

The "RESEAU MATER": An efficient infection control for endometritis, but not for urinary tract infection after vaginal delivery.

Ayzac L, Caillat-Vallet E, Girard R, Berland M; «Réseau Mater».

J Infect Public Health. 2017 Jul - Aug;10(4):457-469. doi: 10.1016/j.jiph.2016.08.002. Epub 2016 Sep 1.

46.

Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.

Girard R, Fam MD, Zeineddine HA, Tan H, Mikati AG, Shi C, Jesselson M, Shenkar R, Wu M, Cao Y, Hobson N, Larsson HBW, Christoforidis GA, Awad IA.

J Neurosurg. 2017 Jul;127(1):102-110. doi: 10.3171/2016.5.JNS16687. Epub 2016 Aug 5.

47.

An Aromatic Diamidine That Targets Kinetoplast DNA, Impairs the Cell Cycle in Trypanosoma cruzi, and Diminishes Trypomastigote Release from Infected Mammalian Host Cells.

Girard RM, Crispim M, Stolić I, Damasceno FS, Santos da Silva M, Pral EM, Elias MC, Bajić M, Silber AM.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5867-77. doi: 10.1128/AAC.01595-15. Print 2016 Oct.

48.

Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.

Girard R, Zeineddine HA, Orsbon C, Tan H, Moore T, Hobson N, Shenkar R, Lightle R, Shi C, Fam MD, Cao Y, Shen L, Neander AI, Rorrer A, Gallione C, Tang AT, Kahn ML, Marchuk DA, Luo ZX, Awad IA.

J Neurosci Methods. 2016 Sep 15;271:14-24. doi: 10.1016/j.jneumeth.2016.06.021. Epub 2016 Jun 23.

49.

Status of the Archaeal and Bacterial Census: an Update.

Schloss PD, Girard RA, Martin T, Edwards J, Thrash JC.

MBio. 2016 May 17;7(3). pii: e00201-16. doi: 10.1128/mBio.00201-16.

50.

Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak.

Fossi Djembi L, Hodille E, Chomat-Jaboulay S, Coudrais S, De Santis N, Gardes S, Mauranne CC, Mourey N, Fredenucci I, Girard R.

J Infect Public Health. 2017 Mar - Apr;10(2):185-190. doi: 10.1016/j.jiph.2016.04.010. Epub 2016 Apr 30.

Supplemental Content

Loading ...
Support Center